FDA Approves First Drug to Treat Alexander Disease

The FDA has approved Zanvastro (zilganersen), the first drug to treat Alexander disease by directly targeting the disease's underlying cause, marking a landmark regulatory approval for this rare neurological disorder.

This Wire brief sits within Fusion42's coverage of Biotech, and 15 sources have reported it between 3 Sep 2026 and 22 Sep 2026.